Gauvreau, G M <br/><br/>
The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma.  [electronic resource] 

 -  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology  04 2018 
 - 445-451 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2222 
<br/><br/><label>Standard No.: </label>10.1111/cea.13114  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Allergens--adverse effects<br/>Anti-Asthmatic Agents--therapeutic use<br/>Asthma--drug therapy<br/>Bronchial Provocation Tests<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Organic Chemicals--therapeutic use<br/>Receptors, CCR3--antagonists & inhibitors